Clinical trial
Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent…
NCT00036972 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00036972 |
|---|---|
| Title | Immunotoxin Therapy Before and After Surgery in Treating Patients With Recurrent Malignant Glioma |
| Official title | Phase I Study to Assess the Histologic Effect and Safety of Pre-Operative and Post-Operative Infusions of IL13-PE38QQR Cytotoxin in Patients With Recurrent Resectable Supratentorial Malignant Glioma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain and Central Nervous System Tumors |
| Intervention type | Biological, Procedure |
| Interventions | cintredekin besudotox, adjuvant therapy, conventional surgery, neoadjuvant therapy |
| Start date | Nov 1, 2001 |
| Primary completion | Jan 1, 2005 |
| Completion | Dec 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 26, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: